DORA-JAPAN

Patient characteristics and prescription patterns of doravirine-based regimen in people living with HIV in Japan - DORA-JAPAN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030250308

Enrollment

300

Registered

2025-08-21

Start date

2025-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV HIV, AIDS

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have received a confirmed diagnosis of HIV 2.Patients who have initiated DOR-based regimen between February 2020 and June 2023 3.Patients aged 18 years or older at the time of DOR initiation

Exclusion criteria

Exclusion criteria: 1. Patients who treated DOR-based regimen in off-label use.

Design outcomes

Primary

Measure	Time frame
-To describe demographic and clinical characteristics -To describe Antiretrovirals prescribed with DOR -To describe ART regimens used during the 6 months prior to DOR initiation in patients who switched to a DOR-based regimen	—

Contacts

Public ContactJunpei Kamimoto

MSD K.K.

jumpei.kamimoto@merck.com+81-3-6272-1000

Outcome results